Literature DB >> 6887664

Recurrent gastric carcinoma--analysis of 100 in-patients--.

T Kano, R Kumashiro, H Masuda, T Okamura, K Inokuchi.   

Abstract

Between 1964 and 1981, 100 in-patients with recurrent gastric carcinoma following curative resection were investigated in the Second Department of Surgery, Kyushu University Hospital. The disease-free interval after initial operation and the advancement of the carcinoma correlated. The mean disease free interval of cases with local recurrence was 4 years and 1 month, that is 2 years longer than in cases of peritoneal dissemination or hematogenous metastasis. The disease free interval and the survival time after recurrence also correlated. Patients with a relapse more than 2 years after initial operation survived statistically longer than did those with a relapse in less than 2 years (p less than 0.01). One and 2 year survival rates after recurrence in the second resection group was 41.4 per cent and 17.2 per cent, respectively. Almost all patients in the other group died within one year after recurrence. The average survival in patients on a combination of chemotherapy and resection of the recurrent tumor was about 2 years and longer than in cases of resection but without chemotherapy.

Entities:  

Mesh:

Year:  1983        PMID: 6887664     DOI: 10.1007/bf02469529

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  4 in total

1.  An interim report upon the second look procedure for cancer of the stomach, colon, and rectum and for limited intraperitoneal carcinosis.

Authors:  O H WANGENSTEEN; F J LEWIS; S W ARHELGER; J J MULLER; L D MACLEAN
Journal:  Surg Gynecol Obstet       Date:  1954-09

2.  The general rules for the gastric cancer study in surgery ad pathology. Part II. Histological classification of gastric cancer.

Authors: 
Journal:  Jpn J Surg       Date:  1981-03

3.  Early detection of recurrence of gastric cancer by serial plasma carcinoembryonic antigen assays.

Authors:  M Iwamatsu; T Saito; T Matsuguchi; R Tamada; K Soejima; K Inokuchi
Journal:  Cell Mol Biol Incl Cyto Enzymol       Date:  1980

4.  Adenocarcinoma of the stomach: review of 1,497 cases.

Authors:  J B Dupont; J R Lee; G R Burton; I Cohn
Journal:  Cancer       Date:  1978-03       Impact factor: 6.860

  4 in total
  2 in total

1.  Prognostic factors in resectable gastric cancer: results of EORTC study no. 40813 on FAM adjuvant chemotherapy.

Authors:  M Lise; D Nitti; A Marchet; T Sahmoud; N Duez; A Fornasiero; J G dos Santos; R Labianca; P Lasser; M Gignoux
Journal:  Ann Surg Oncol       Date:  1995-11       Impact factor: 5.344

2.  Experimental and clinical studies on the intraperitoneal administration of cis-diamminedichloroplatinum (II) for peritoneal carcinomatosis caused by gastric cancers.

Authors:  T Furukawa; K Kumai; T Kubota; S Hirahata; H Shimizu; H Matsui; T Takahara; K Aizawa; S Shibata; A Shimada
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.